StreetInsider.com News Articles

Form 6-K GENMAB A/S For: Jun 17

Wed, 17 Jun 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260617/26658547.html

Form 6-K GENMAB A/S For: Jun 17

Wed, 17 Jun 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260617/26658547.html

Form 6-K GENMAB A/S For: Jun 17

Wed, 17 Jun 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260617/26658547.html

Form 6-K GENMAB A/S For: Jun 16

Tue, 16 Jun 2026 15:37:00 -0400

si-local-file:///var/storage/secattach/20260616/26653783.html

Form 6-K GENMAB A/S For: Jun 16

Tue, 16 Jun 2026 15:37:00 -0400

si-local-file:///var/storage/secattach/20260616/26653783.html

Form 6-K GENMAB A/S For: Jun 16

Tue, 16 Jun 2026 15:37:00 -0400

si-local-file:///var/storage/secattach/20260616/26653783.html

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Tue, 16 Jun 2026 15:12:00 -0400

Company Announcement

COPENHAGEN, Denmark; June 16, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 185 shares as a consequence of the exercise of employee warrants.

The increase is effected without any preemption rights for the existing shareholders of the Company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:

185 shares at DKK 1,334.50.

Proceeds to the Company are approximately DKK 0.2 million. The increase corresponds to less than 0.001%of the Company's share capital.

The new shares are ordinary

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Tue, 16 Jun 2026 15:12:00 -0400

Company Announcement

COPENHAGEN, Denmark; June 16, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 185 shares as a consequence of the exercise of employee warrants.

The increase is effected without any preemption rights for the existing shareholders of the Company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:

185 shares at DKK 1,334.50.

Proceeds to the Company are approximately DKK 0.2 million. The increase corresponds to less than 0.001%of the Company's share capital.

The new shares are ordinary

Form 6-K GENMAB A/S For: Jun 15

Mon, 15 Jun 2026 12:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26646160.html

Form 6-K GENMAB A/S For: Jun 15

Mon, 15 Jun 2026 12:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26646160.html

Form 6-K GENMAB A/S For: Jun 15

Mon, 15 Jun 2026 12:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26646160.html

Major Shareholder Announcement

Mon, 15 Jun 2026 12:04:00 -0400

Company Announcement

Major shareholder announcement for Genmab A/S

COPENHAGEN, Denmark; June 15, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis Investment Management Limited has informed us that through shares, as of June 12, 2026, Orbis Investment Management Limited controlled the voting rights to 3,112,476 shares in Genmab A/S, which amounts to 4.99% of the share capital and voting rights in Genmab A/S.